|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prevalent vertebral fractures among children initiating glueocortieoid therapy for the treatment of rheumatic disorders 显示文摘 | Huber AM Gaboury I Cabral DA | 2010 | Arthritis Care Res (Hobo- ken)2010，62，： | 1 |
| 2 | Analysis of the best site on the stapes footplate for ossicular chain reconstruction显示文摘 | Asai M Huber AM Goode RL | 1999 | Acta Otolaryngol1999，119，： | 1 |
| 3 | Phase- sensitive inversion-recovery MR imaging in the detection of myocardial infarction显示文摘 | HUBER AM SCHOENBERG SO HAYES C | 2005 | Radiology2005，237，3： | 1 |
| 4 | A new implantable middle ear hearing device for mixed hearing loss: a feasibility study in human temporal bones显示文摘 | Huber AM Ball GR Veraguth D | 2006 | Otol Neurotol2006，27，8： | 1 |
| 5 | A randomized, placebo controlled trial of prednisone in early Henoch-Schonleinpurpura 显示文摘 | Huber AM King J McLaine P | 2004 | BMC Medicine2004，10，2： | 1 |
| 6 | Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis: physician and patient/parent global activity, manual muscle testing (MMT), health assessment questionnaire (HAQ)/ child-hood health assessment questionnaire (C-HAQ), childhood myositis assessment scale (CMAS), myositis disease activity assessment tool (MDAAT), disease activity score (DAS), short form 36 (SF-36), child health questionnaire (CHQ), physician global damage, myositis damage index (MDI), quantitativemuscle testing (QMT), myositis functional index-2 (FI-2), myositis activities profile (MAP), inclusion body myositis func- tional rating scale (IBMFRS), gutaneous dermatomyositis disease area and severity index (CDASI), gutaneous assessment tool (CAT), dermatomyositis skin severity index (DSSI), skindex, and Dermatology life quality index (DLQ显示文摘 | Rider LG Werth VP Huber AM | 2011 | Arthritis Care Res (Hoboken)2011，63，11： | 1 |
| 7 | Coxsackievirus B3 in- duces T regulatory cells, which inhibit cardiomyopathy in tumor necrosis factor-alpha trasgenic mice 显示文摘 | Huber SA Feldman AM Sartini D | 2006 | Circ Res2006，99，10： | 1 |
| 8 | A randomized,placebo-controlled trial of prednisone in early Henoch-Sch(o)nlein purpura显示文摘 | Huber AM King J McLaine P | 2004 | BMC Med2004，2，1： | 1 |
| 9 | Structural and functional analysis of human SIRT1 显示文摘 | Davenport AM Huber FM Hoelz A | 2014 | J Mol Biol2014，426，3： | 1 |
| 10 | A randomized, placebo- controlled trial of prednisone in early Henoch-Schonlein pur- pura显示文摘 | Huber AM King J McLaine P | 2004 | BMC Med2004，2，： | 1 |
| 11 | A randomized,placebocontrolled trial of prednisone in early Henoch-Schonlein purpura显示文摘 | Huber AM King J Mclaine P | | 0，，07： | 1 |
| 12 | A randomized,placebo-controlled trial of prednisone in early Henoch Sch(o)nlein Purpura显示文摘 | Huber AM King J McLaine P | | 0，，： | 1 |
| 13 | A randomized, placebo - con- trolled trial of prednisone in early Henoch Schtinlein purpura显示文摘 | Huber AM King J McLaine P | 2004 | BMC Med2004，2，： | 1 |
| 14 | 显示文摘 | Zubiaga AM Munoz E Huber BT | 1992 | J Immunol1992，149，： | 1 |
| 15 | Review of risk and protective factors of substance use and problem use in emerging adulthood显示文摘 | Stone AL Becker LG Huber AM | 2012 | Addict Behav2012，37，7： | 1 |
| 16 | A randomized, placebo - controlled trial of prednisone in early Henoch Schonlein purpura 显示文摘 | Huber AM King J McLaine P | 2004 | BMC Med2004，2，： | 1 |
| 17 | A randomized, pla- cebo-controlled trial of prednisone in early Henoch-Schonlein purpura 显示文摘 | Huber AM King J McLaine P | 2004 | BMC Med2004，2，7： | 1 |
| 18 | A randomized,placebo-controlled trial of prednisone in early Henoch-Schonlein Purpura显示文摘 | Huber AM King J McLaine P | 2004 | BMC Med2004，10，2： | 1 |
| 19 | A randomized,placebo-con- trolled trial of prednisone in early Henoch-Sch~nlein purpura 显示文摘 | Huber AM King J McLaine P | 2004 | BMC Med2004，，2： | 1 |
| 20 | A randomized, placebo - controlled trial of prednisone in eary Henoch - Schonlein Purpura 显示文摘 | Huber AM King J Mc Laine P | 2004 | BMCMed2004，2，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员